Vashi, P., Batt, K., Klamroth, R., Mancuso, M., Majewska, R., Mantovani, L. (2020). MATCHING-ADJUSTED INDIRECT COMPARISONS OF ANNUALIZED BLEEDING RATE AND TREATMENT UTILIZATION BETWEEN EXTENDED HALF-LIFE RECOMBINANT FACTOR VIII PRODUCTS, BAY 94-9027 AND TUROCTOCOG ALFA PEGOL, FOR PROPHYLAXIS OF SEVERE HAEMOPHILIA A. VALUE IN HEALTH, 23(S2), 690-690.

MATCHING-ADJUSTED INDIRECT COMPARISONS OF ANNUALIZED BLEEDING RATE AND TREATMENT UTILIZATION BETWEEN EXTENDED HALF-LIFE RECOMBINANT FACTOR VIII PRODUCTS, BAY 94-9027 AND TUROCTOCOG ALFA PEGOL, FOR PROPHYLAXIS OF SEVERE HAEMOPHILIA A

Mantovani, LG
2020

Abstract in rivista
Health Care Sciences
English
2020
23
S2
690
690
PRO4
none
Vashi, P., Batt, K., Klamroth, R., Mancuso, M., Majewska, R., Mantovani, L. (2020). MATCHING-ADJUSTED INDIRECT COMPARISONS OF ANNUALIZED BLEEDING RATE AND TREATMENT UTILIZATION BETWEEN EXTENDED HALF-LIFE RECOMBINANT FACTOR VIII PRODUCTS, BAY 94-9027 AND TUROCTOCOG ALFA PEGOL, FOR PROPHYLAXIS OF SEVERE HAEMOPHILIA A. VALUE IN HEALTH, 23(S2), 690-690.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/602955
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
Social impact